Real-time enrollment status for this mild autonomous cortisol secretion clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 4:55 PM UTC
| NCT Number | NCT07649317 |
| Recruiting Status | Recruiting |
| Condition | Mild Autonomous Cortisol Secretion |
| Phase | PHASE1 |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Last Updated on CT.gov | August 3, 2026 (3 weeks ago) |
As of August 28, 2026: Clinical trial NCT07649317 is currently recruiting participants. This phase1 study for mild autonomous cortisol secretion is actively seeking new participants at 1 location across the United States. The study is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07649317 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07649317 was last updated 3 weeks ago (August 3, 2026). HelloStudys verifies this status automatically.